Paul G. Kemps

ALK-positive histiocytosis: a new clinicopathologic spectrum highlighting neurologic involvement and responses to ALK inhibition

Paul G. Kemps, Jennifer Picarsic, Benjamin H. Durham et al. · Blood · 2021 · 155 citations · Full text

Medicine, Oncology, Pathology +17

Spectrum of histiocytic neoplasms associated with diverse haematological malignancies bearing the same oncogenic mutation

Paul G. Kemps, Konnie M. Hebeda, Steven T. Pals et al. · The Journal of Pathology Clinical Research · 2020 · 55 citations · Full text

Medicine, Hematology, Pathology +14

Clinicogenomic associations in childhood Langerhans cell histiocytosis: an international cohort study

Paul G. Kemps, Timo C. E. Zondag, Helga B. Arnardóttir et al. · Blood Advances · 2022 · 50 citations · Full text

Medicine, Genetics, Oncology +17

Bone marrow–derived myeloid progenitors as driver mutation carriers in high- and low-risk Langerhans cell histiocytosis

Yanling Xiao, Astrid G. S. van Halteren, Xin Lei et al. · Blood · 2020 · 38 citations · Full text

Life Sciences, Genetics, Molecular Genetics +13

<i>BRAF</i> V600E is associated with higher incidence of second cancers in adults with Langerhans cell histiocytosis

Aldo A. Acosta‐Medina, Paul G. Kemps, Timo C. E. Zondag et al. · Blood · 2023 · 26 citations · Full text

Medicine, Oncology, Pathology +12